Martin Zimmermann

13.4k total citations
118 papers, 5.0k citations indexed

About

Martin Zimmermann is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Oncology. According to data from OpenAlex, Martin Zimmermann has authored 118 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Public Health, Environmental and Occupational Health, 62 papers in Hematology and 31 papers in Oncology. Recurrent topics in Martin Zimmermann's work include Acute Lymphoblastic Leukemia research (73 papers), Acute Myeloid Leukemia Research (55 papers) and Childhood Cancer Survivors' Quality of Life (26 papers). Martin Zimmermann is often cited by papers focused on Acute Lymphoblastic Leukemia research (73 papers), Acute Myeloid Leukemia Research (55 papers) and Childhood Cancer Survivors' Quality of Life (26 papers). Martin Zimmermann collaborates with scholars based in Germany, Austria and Czechia. Martin Zimmermann's co-authors include Dirk Reinhardt, Ursula Creutzig, Martin Schrappe, Alfred Reiter, Michael Dworzak, Jan Starý, Karl Welte, Martin Stanulla, Hansjörg Riehm and Thomas Lehrnbecher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Martin Zimmermann

114 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Zimmermann Germany	40	2.7k	2.6k	1.3k	1.2k	1.1k	118	5.0k
M Zimmermann Germany	29	2.3k 0.9×	2.3k 0.9×	1.1k 0.9×	802 0.7×	634 0.6×	61	3.7k
Erik Forestier Sweden	36	2.9k 1.1×	2.3k 0.9×	1.5k 1.2×	1.0k 0.9×	745 0.7×	109	4.2k
Renato Bassan Italy	32	2.1k 0.8×	2.4k 0.9×	567 0.5×	664 0.6×	1.2k 1.0×	164	4.2k
W M Crist United States	41	2.3k 0.8×	1.9k 0.7×	970 0.8×	1.4k 1.2×	2.0k 1.8×	75	6.1k
Andrew McMillan United Kingdom	32	2.2k 0.8×	1.9k 0.7×	723 0.6×	388 0.3×	2.4k 2.1×	117	5.5k
Minnie Abromowitch United States	33	1.8k 0.7×	1.1k 0.4×	784 0.6×	454 0.4×	584 0.5×	67	3.0k
Carlos Graux Belgium	27	1.4k 0.5×	2.2k 0.8×	288 0.2×	1.1k 0.9×	980 0.9×	91	3.6k
Lloyd E. Damon United States	27	668 0.2×	1.5k 0.6×	279 0.2×	781 0.7×	932 0.8×	110	3.8k
Uday Popat United States	43	936 0.3×	4.0k 1.6×	266 0.2×	1.3k 1.1×	1.9k 1.7×	396	6.6k
André Delannoy Belgium	26	1.4k 0.5×	1.5k 0.6×	561 0.4×	271 0.2×	581 0.5×	104	2.9k

Countries citing papers authored by Martin Zimmermann

Since Specialization

Citations

This map shows the geographic impact of Martin Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Zimmermann more than expected).

Fields of papers citing papers by Martin Zimmermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Zimmermann. The network helps show where Martin Zimmermann may publish in the future.

Co-authorship network of co-authors of Martin Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Zimmermann. A scholar is included among the top collaborators of Martin Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Zimmermann. Martin Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergmann, Anke K., Martin Zimmermann, Gunnar Cario, et al.. (2025). Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax. Leukemia. 39(6). 1520–1525.

Müller, Stephanie, Claudia Sopalla, Claudia Lanvers‐Kaminsky, et al.. (2024). Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcome. Blood. 144(13). 1412–1417. 1 indexed citations

Damm‐Welk, Christine, Federica Lovisa, Elisa Carraro, et al.. (2022). Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?. Cancers. 14(7). 1703–1703. 11 indexed citations

Rasche, Mareike, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2021). Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group. Cancers. 13(4). 789–789. 15 indexed citations

Bhayadia, R, Michelle Ng, Stephan Emmrich, et al.. (2021). The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis. Blood. 139(5). 651–665. 24 indexed citations

Würthwein, Gudrun, Claudia Lanvers‐Kaminsky, Joachim Gerß, et al.. (2021). Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data. European Journal of Drug Metabolism and Pharmacokinetics. 46(2). 289–300. 9 indexed citations

Woessmann, Wilhelm, Martin Zimmermann, Andrea Meinhardt, et al.. (2020). Progressive or Relapsed Burkitt Lymphoma or Leukemia in Children and Adolescents after BFM-type First-line Therapy. Blood. 135(14). 1124–1132. 30 indexed citations

Au-Yeung, Rex, Laura Padilla, Martin Zimmermann, et al.. (2020). Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group. British Journal of Haematology. 190(5). 753–763. 41 indexed citations

Niktoreh, Naghmeh, Christiane Walter, Martin Zimmermann, et al.. (2019). MutatedWT1,FLT3-ITD,andNUP98-NSD1Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia. Journal of Oncology. 2019. 1–15. 47 indexed citations

10.

Iglesias, Pablo, Julia Strauß, Ann‐Christin Puller, et al.. (2019). Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair. Oncogene. 38(19). 3616–3635. 14 indexed citations

11.

Hinze, Laura, Stefanie V. Junk, Norman W. Klein, et al.. (2017). Genome-Wide Association Study (GWAS) of High-Risk Minimal Residual Disease and Relapse in B-Cell Acute Lymphoblastic Leukemia on Trial AIEOP-BFM ALL 2000. Blood. 130. 3981–3981. 1 indexed citations

12.

Макарова, О. В., Ilske Oschlies, Stephanie Müller, et al.. (2017). Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma. British Journal of Haematology. 182(5). 735–739. 9 indexed citations

13.

Rohde, Marius, Bettina R. Bonn, Martin Zimmermann, et al.. (2017). Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols. Haematologica. 102(6). 1091–1098. 32 indexed citations

14.

Kaspers, Gertjan J.L., Martin Zimmermann, Dirk Reinhardt, et al.. (2013). Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group. Journal of Clinical Oncology. 31(5). 599–607. 152 indexed citations

15.

Creutzig, Ursula, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2013). Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood. 122(1). 37–43. 123 indexed citations

16.

Neuhoff, Christine von, Dirk Reinhardt, Annette Sander, et al.. (2010). Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98. Journal of Clinical Oncology. 28(16). 2682–2689. 140 indexed citations

17.

Conter, Valentino, Maria Grazia Valsecchi, Daniela Silvestri, et al.. (2007). Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial. The Lancet. 369(9556). 123–131. 60 indexed citations

18.

Kawamata, Norihiko, Seishi Ogawa, Martin Zimmermann, et al.. (2007). Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high resolution single nucleotide polymorphism oligonucleotide microarray.. Cancer Research. 67. 389–389. 4 indexed citations

19.

Vorwerk, Peter, Klaus Mohnike, Heike Wex, et al.. (2005). Insulin-Like Growth Factor Binding Protein-2 at Diagnosis of Childhood Acute Lymphoblastic Leukemia and the Prediction of Relapse Risk. The Journal of Clinical Endocrinology & Metabolism. 90(5). 3022–3027. 26 indexed citations

20.

Popp, Susanne, Martin Granzow, Brigitte Schoell, et al.. (2001). Comparative genomic hybridization in childhood acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 124(2). 89–97. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact